About us
ABOUT US
We manufacture meticulously crafted antibody-oligo conjugates, bringing genomics-inspired multiplexing to proteomics. Our mission is to empower scientists to explore the proteome more efficiently, accelerating discovery through reproducible, amplified experimental results. These values are reflected in our company name and slogan:
AbOliGo - fast, reproducible, antibody conjugates for all.
Discover New Reagent Solutions
Our reagents are designed to meet the diverse needs of researchers and scientists. We offer a wide range of products, including enzyme kits, chemical reagents, and diagnostic tools, all aimed at enhancing laboratory efficiency and accuracy.
Focus on the researcher – understand their needs and deliver exceptional solutions.
Transforming research capabilities is achievable.
We’ve proven it time and again.
Meet our dedicated team
Expert professionals driving our innovation
Dr. Brian Carpenter
Chief Executive Officer/Co-Founder
Brian has extensive product management experience for antibodies (£100 million annualized revenue) and conjugation reagents. His market insights helped steer the £100 million acquisition price of Expedeon.
Brian holds a PhD from the University of Dundee and completed postdoctoral work at UCSF.
Dr. Nicholas Hutchings
Co-Founder
Nick is a serial entrepreneur who has successfully launched and sold antibody businesses for a total value of £75 million+. The latest being Absolute Antibody who pioneered the development of recombinant antibodies for research, therapeutics and diagnosis.
Nick studied Biochemistry at the University of Oxford followed by a doctorate at the Sir William Dunn School of Pathology supervised by Prof Neil Barclay.
Dr Nick Gee
Co-Founder
Nick, a pioneer in the antibody bioconjugation market, founded Innova Biosciences, which was sold to Expedeon for approximately £10 million and later acquired by Abcam for £100 million.
Nick is a biochemist who has over twenty years of bioconjugation and is a named inventor of several oligo-conjugation related patents.
Mick Knowles
Co-Founder/Head of Reagents
Mick Knowles with over twenty years of conjugation expertise, is a named inventor on several conjugation patents, and led the development of Sigma’s Duolink Probemaker oligo conjugation system and O-Link Proteomics Target 96 oligo conjugation panels.
Mick has a rich operational background including scaling manufacturing, building highly engaged teams, and maintaining ISO quality systems.